Vanda Pharmaceuticals Inc (NASDAQ:VNDA)
| 11.69 Delayed Data As of Jul 06 |  +0.19 / +1.65%Today’s Change | 9.24 Today|||52-Week Range 21.44 | -25.49% Year-to-Date |
Latest VNDA News | Press Releases
| Bluebird (BLUE) Surges 18%: Is This an Indication of Further Gains? Jul 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 11.50 |
| Today’s open | 11.48 |
| Day’s range | 11.47 - 11.80 |
| Volume | 26,275 |
| Average volume (3 months) | 551,459 |
| Market cap | $633.0M |
Data as of 4:00pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | +39.18% |
| Earnings growth (this year) | -43.10% |
| Earnings growth (next 5 years) | +36.12% |
| Revenue growth (last year) | +8.27% |
| P/E ratio | 36.5 |
| Price/Sales | 3.32 |
| Price/Book | 1.24 |
Competitors
Data as of 4:00pm ET, 07/06/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | $0.13 |
| Annual revenue (last year) | $268.7M |
| Annual profit (last year) | $33.2M |
| Net profit margin | 12.34% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Washington, District Of Columbia |
Forecasts
